Morning Briefing
Summaries of health policy coverage from major news organizations
Federal Regulators To Slap Warnings On Sleeping Pills Because Of Drugs' Risky Side Effects
Federal health regulators announced on Tuesday that they would require manufacturers of sleeping pills such as Ambien and related drugs to post strongly worded warnings in boxes on labels and patient guides. The Food and Drug Administration, in what it called a safety announcement, noted that the drugs鈥 side effects included risky behaviors, such as sleepwalking and sleep driving, that can lead to injury and even death. (Carey, 4/30)
The FDA said on Tuesday prescription insomnia pills that contain eszopiclone, zaleplon and zolpidem would have to display a black-box warning about potential risks and a contraindication that they shouldn鈥檛 be taken by patients who have experienced complications such as sleepwalking or driving while asleep. (Armental, 4/30)
There were 46 reports of serious injuries that weren鈥檛 deadly, including overdoses, burns, loss of limbs from extreme cold, and self-injuries from gunshot wounds. 鈥淭hese incidents can occur after the first dose of these sleep medicines or after a longer period of treatment, and can occur in patients without any history of these behaviors and even at the lowest recommended doses,鈥 FDA Acting Commissioner Ned Sharpless said in a statement. 鈥淲hile these incidents are rare, they are serious and it鈥檚 important that patients and health-care professionals are aware of the risk.鈥 (Cortez, 4/30)